Cipla Q3 Results FY2023, PAT at Rs.801 crores


On 25th January 2023, Cipla announced its results for the third quarter of FY2023.
Key Highlights:
- Revenues from operations at Rs. 5810 crores
- EBITDA stood at Rs. 1408 crores
- The company reported PAT at Rs. 801 crores
Business Highlights:
- One-India business segment reported a robust double-digit traction in the core portfolio across therapies and business segments; 11% YoY ex-covid growth
- US business reported highest ever quarterly revenue of $195 Million and 30% YoY growth; Strong traction in the differentiated portfolio including market share expansion in key respiratory and peptide injectable products
- South Africa, Sub-Saharan Africa, And Global Access (SAGA) business’ supply challenges being addressed
- International Markets reported revenue impacted by currency volatility; 6% YoY ex-covid growth in INR terms
- API continued growth in emerging markets offsetting normalization in inventory levels for European customers
- R&D investments stand at Rs. 363 crores or 6.2 % of sales; Higher 39% YoY driven by ongoing clinical trials on a respiratory asset and other developmental efforts continuing including biosimilars
Commenting on the results, Umang Vohra, MD and Global CEO, Cipla Ltd, said: “Our Q3FY23 performance reflects sustained momentum in core One-India and US businesses driving our overall revenue growth of 6% reported and 11% on an excovid basis. Our One India franchise delivered strong performance across therapies and segments with double-digit market-beating growth in prescription on a covid adjusted base. We achieved the highest-ever quarterly revenue for the North American region of $195 Mn driven by the contribution of differentiated products and market share expansion in flagship respiratory and peptide franchises. Our reported operating profitability of 24.2% reflects our focused efforts on navigating external headwinds and continued higher R&D spending stemming from ongoing respiratory trials and initiation of biosimilar programs.”
Share Market Today
Indices Name | Price | Price Change (% change) |
---|---|---|
S&P ASX 200 | 7064.30 | 8.1 (0.11%) |
CAC 40 | 7123.88 | -60.94 (-0.85%) |
DAX | 15405.49 | -151.8 (-0.98%) |
Dow Jones | 33915.67 | -48.17 (-0.14%) |
FTSE 100 | 7623.99 | -59.92 (-0.78%) |
Hang Seng | 17734.04 | -344.65 (-1.91%) |
US Tech 100 | 13244.59 | 27.78 (0.21%) |
Nikkei 225 | 32678.62 | 276.21 (0.85%) |
S&P 500 | 4325.71 | 5.65 (0.13%) |
Gift Nifty | 19714.00 | 71.5 (0.36%) |
Shanghai Composite | 3115.61 | -16.82 (-0.54%) |
Taiwan Weighted | 16452.23 | 107.75 (0.66%) |
US 30 | 33919.30 | -89.7 (-0.26%) |
Start Investing in 5 mins*
Rs. 20 Flat Per Order | 0% Brokerage
Fill in your details below: